CLINICAL AND PROGNOSTIC SIGNIFICANCE OF NO LEVELS AND FMD TEST IN ENDOTHELIAL FUNCTION ASSESSMENT IN PREGNANT WOMEN WITH HYPERTENSION

Objective: to assess endothelial function in pregnant women with pre-existing hypertension using Flow-mediated vasodilatation test and level of nitric oxide (NO) concentration. Design and method: Study included 55 pregnant women of 2 groups. First group (n=34) of healthy pregnant women. Second group (n=24) of women with pre-existing hypertension. Endothelial function was also analyzed using flow-mediated dilation (FMD) test and level of nitric oxide (NO) concentration. NO level were assessed by P.P. Golikov method. Statistical processing was carried out using the Statistica 13.0 program. P < 0.05 was considered statistically significant. Results: there was no significant difference in age (27 in 1 group vs 29 in 2 group, P = 0.0658) and number of pregnancies (3.3 in 1 group vs 3.2 in 2 group, P = 0.7920). Mean level of blood pressure in group hypertension was: systolic blood pressure (SBP) of 153.83 mmHg. vs 102.72 mmHg in group 1 (P <0.0001), diastolic blood pressure (DBP) 96.16mmHg. vs 64.77 mmHg. in 1st group (P <0.0001). 23 women (95.8%) with hypertension were overweight, of which 15(62.5%) with obesity of I and II degree. In healthy group only 7 women (16%) were overweight, and no obese women. Mean value of FMD for 1 group was 6.2% vs 4.82 (P <0.0001), meanwhile NO was 8.8 mmol/l in group 1 vs NO 13.7 mmol/l (P <0.0001). Conclusions: Flow-mediated vasodilatation test measured by using an ultrasound system and determination of the blood serum NO level is associated with early diastolic dysfunction in overweight pregnant women with CHT.

Hali tarjima qilinmagan